Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

Nippon Express Obtains GDP Certification of Compliance with WHO Standards at East Japan Pharmaceutical Center

- Dedicated Pharmaceutical Logistics Facility Offers Storage and Transport in Two Temperature Ranges - TOKYO, Sept. 14, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereafter "Nippon Express"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) cert...

2022-09-14 14:00 1719

Fosun: Foreign Media Reports about "Regulatory Authorities Asking Banks to Examine their Exposure to Fosun" are Completely False

HONG KONG, Sept. 14, 2022 /PRNewswire/ -- In response to foreign media reports about "Chinese regulatory authorities asking banks and some of the state-owned companies to examine their exposure to Fosun" on 13 September, Fosun said such reports are completely false. It is understood that Fosun h...

2022-09-14 12:11 2576

Antengene Unveils Its First Australian Office to Continue Expanding Global Presence

SHANGHAI and HONG KONG, Sept. 14, 2022 /PRNewswire/ -- Antengene recently unveileda new office space situated in Melbourne, Australia's most sought-after CBD, taking another important step in the company's continued global expansion. The new office offers an appealing environment that will help An...

2022-09-14 08:30 3281

Antengene Unveils Its First Australian Office to Continue Expanding Global Presence

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future LAUSANNE, Switzerland, Sept. 14, 2022 /PRNewswire/ -- Debiopharm Innovation Fund, the strategic investm...

2022-09-14 00:48 1420

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

BIRMINGHAM, England, Sept. 13, 2022 /PRNewswire/ -- Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trialFOR MagicTouch S...

2022-09-13 22:15 1763

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

An oral Tyrosine Kinase Inhibitor of HER2 Exon20 Insertion, for the Treatment of Non-Small Cell Lung Cancer TAIPEI, Sept. 13, 2022 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announ...

2022-09-13 22:00 1846

Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics

The proprietary platform is versatile, equally effective with different cargoes, routes of administration MOUNTAIN VIEW, Calif., Sept. 13, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today ann...

2022-09-13 20:38 1557

CStone announces China's NMPA has accepted and granted priority review to the supplemental new drug application (sNDA) for sugemalimab in the treatment of patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)

* This is the third supplemental new drug application (NDA) that CStone has submitted for sugemalimab after the prior two for stage III and IV non-small cell lung cancer. Sugemalimab has the potential to become the world's first immuno-oncology therapy to be approved for patients with relapsed ...

2022-09-13 08:02 2752

Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022

* In first line treatment of advanced or metastatic G/GEJ cancer, early interim data of the first 15 patients with measurable disease receiving the combination of TST001 (Osemitamab) with CAPOX demonstrated a partial response rate of 73.3% and a disease control rate of 100% per RECIST1.1. * B...

2022-09-13 08:00 2116

Starpharma presents compelling data in Prostate Cancer at ESMO

MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- Cabazitaxel (Jevtana, Sanofi) is a market leading chemotherapy for the treatment of advanced prostate cancer (mCRPC). Developed by Australian biotech company Starpharma, DEP® cabazitaxel is a patented, highly water soluble dendrimer nanopartic...

2022-09-13 06:28 1399

Starpharma presents compelling data in Prostate Cancer at ESMO

EpiVax Secures Additional Funding from FDA for Immunogenicity Risk Assessment for Biosimilar Products

PROVIDENCE, R.I., Sept. 13, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce the award of a two-year,$2 million grant from the FDA's Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) for ...

2022-09-13 00:24 1530

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

* Revenue of US$51.7 million in the second quarter of 2022 * Loss from operations of US$(17.9) million and adjusted EBITDA[1] of US$6.5 million in the same period * Raises full year adjusted EBITDA guidance to the range of US$35 million to US$45 million, with corresponding full year revenue ...

2022-09-09 23:17 5672

YishengBio Received Approvals From Philippines and UAE For Phase 2 / 3 Clinical Trials of PIKA Recombinant COVID-19 vaccine

BEIJING, Sept. 8, 2022 /PRNewswire/ -- YishengBio Co., Ltd., ("YishengBio"), a biopharmaceutical company dedicated to discovery, development, manufacturing and commercialization of new generations of vaccines and therapeutic biologics, announced that the Company received the approvals from the re...

2022-09-08 21:33 2360

ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS

* International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics * The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the ...

2022-09-08 16:41 1450

Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study

ROCKVILLE, Md. and SUZHOU, China, Sept. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology...

2022-09-08 08:05 3056

TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action

VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus (African a...

2022-09-07 14:32 2621

Sirnaomics to Present at 3rd Annual Jefferies Asia Forum

GAITHERSBURG, Md. and SUZHOU, China, Sept. 7, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dr.Patrick Lu, PhD, founder, Chairman of the Board, ...

2022-09-07 11:32 2994

Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

SAN FRANCISCO, Sept. 6, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced that Chief Executive OfficerPiers Ingram, Ph.D., and Chief Financial Office...

2022-09-06 20:00 2120

Prospection partners with leading Japanese healthcare data provider Medical Data Vision to improve treatment access for patients

SYDNEY, Sept. 6, 2022 /PRNewswire/ -- Health analytics pioneer, Prospection has announced a unique global data access agreement with leading Japanese medical data company Medical Data Vision Co., Ltd. (MDV) to accelerate healthcare analytics globally. The agreement, covering the world's second...

2022-09-06 07:34 1806

Thailand heightens its healthcare hub ambition with integrative medicine

BANGKOK, Sept. 5, 2022 /PRNewswire/ -- Living with the COVID-19 pandemic, people start to recognize the equal importance of modern medicine and preventive practices in maintaining their good health and wellbeing. With a strong healthcare and wellness infrastructure and reputation for highly-skill...

2022-09-05 15:22 2971

Thailand heightens its healthcare hub ambition with integrative medicine

1 ... 61 62 636465 66 67 ... 181